IMIDAFENACIN, A NOVEL ANTICHOLINERGIC AGENT WITH LOW SIDE EFFECTS, SHOWS EQUIVALENT EFFICACY TO SOLIFENACIN IN OVERACTIVE BLADDER PATIENTS – GAP (Global Assessment Study of Anticholinergics on Efficacy and Tolerability for Patients with OAB) STUDY IN JAPAN

Nishii H1, Inoue M2, Ito K3, Fukai K4, Sakamoto S5, Ito K6, Matsushita M7, Haga K8, Matsumoto T9

Abstract Category

Detrusor Overactivity

Abstract 338
Non-Discussion Posters
Scientific Non Discussion Poster Session 29
1. Department of Urology, University of Occupational and Environmental Health, Japan; Fukuoka Institute of Occupational Health, 2. Department of Oral Biological Science, Division of Dysphagia Rehabilitation, Niigata University Graduate School of Medical and Dental Sciences, 3. Geriatric Dentistry, Niigata University Medical and Dental Hospital, 4. Graduate School of Health Sciences, Okayama University, 5. Department of Urology, Nakamura Hospital, 6. Ito Urology Clinic, 7. Matsushita Urologic Clinic, 8. Sanjukai Urological Hospital, 9. Department of Urology, University of Occupational and Environmental Health, Japan
Links

Abstract

22/11/2024 17:56:33